ADVERTISEMENT

Should I Invest In Royal Orchid Hotels, UPL Or Infosys? #AskBQ

Should I Invest In Royal Orchid Hotels, UPL Or Infosys? #AskBQ

People monitor market news outside the Bombay Stock Exchange (BSE) building. (Photographer: Adeel Halim/Bloomberg)
People monitor market news outside the Bombay Stock Exchange (BSE) building. (Photographer: Adeel Halim/Bloomberg)

#AskBQ is BloombergQuint’s daily offering where market experts help investors make the right investment decisions in the equities market.

In this episode, Brijesh Singh of StockAxis Capital and Sandeep Jain of Tradeswift Broking gave their views on Royal Orchid Hotels, UPL, Infosys and many more.

Watch the full conversation here:

Nikhil: Bought Royal Orchid Hotels at Rs 210. Is this the right time to exit the stock ?

Brijesh Singh: Immediate resistance for the stock lies at Rs 191-192. Recommend holding on to the stock with a stop loss of Rs 169. Expect stock to touch Rs 205-207 levels, anything above Rs 207, next level to watch would be Rs 225.

Kartik Mahadevan: Holding 50 shares of Schaeffler India at average price of Rs 2000. Should I hold it for the next 3-5 years.

Sandeep Jain: Recommend to stay invested in the stock. It will fetch good returns in the long term.

Ujjwal Kumar: I am holding 30 shares of UPL at Rs 810 and 25 shares of GIC Housing Finance at Rs 480. Shall I average at current price or wait for some more corrections ?

Sandeep Jain: The investor can try to average marginally at current levels. Rs 650-670 can be a good range to start averaging UPL. Suggest holding on to GIC Housing at current levels.

Vishwa Kalra: Is it good to go short on Infosys at current levels ?

Brijesh Singh: Overall trend of the chart still in bullish mode. Would not recommend going short at current levels. 1275-1285 a resistance zone for Infosys and one can short at those levels with a strict stop loss of 1300 and a target of Rs 1225-1230.

Ramesh Parmela: Which stock should I buy to replace Glenmark Pharma at current levels ?

Sandeep Jain: Aurobindo Pharma is a good pick in the largecap pharma space. Syngene, IPCA Labs, Glenmark and Suven Lifespaces are also good bets at current levels.

Sanjeev Khajuria: Holding 200 shares of BSE Ltd at Rs 900 per share and 1000 shares of PTC India Finacial at Rs 33. What should I do with these stocks ?

Sandeep Jain: BSE is an attractive buy at current levels, it can be a multi-bagger for the long term. Recommend not to exit PTC India Financial Services at current levels, can average it.

Sandeep Sharma: I am holding Innovators Facade Systems at Rs 72 and Fineotex Chemicals at Rs 61. Can i hold these stocks for 1-2 years.

Brijesh Singh: The investor can hold on to the stock with a target of Rs 90 in the long term with a stop loss of Rs 50-55.

Rangarajan Balakrishnan: Can you suggest some short term trades in the banking or metals sector ?

Brijesh Singh: One can invest in SAIL. One can also look to invest in JSW Steel at around Rs 330 with a stop loss of Rs 315 and a target of Rs 355-360. Among banking stocks, one can buy RBL Bank at around 530-535 with a stop loss of Rs 520 and a target of over Rs 600 in the next one year.

Rizwan Hawaldar: I bought 500 Tata Motors for Rs 331. What should I do with the stock if I have a 6 month perspective.

Sandeep Sharma: Investors can hold on to the stock. They can also start averaging the stock at Rs 280-290 levels if it corrects.

Analysts’ disclosure: Both the analysts do not have any financial interests and do not hold any stocks discussed today.

Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.

Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.

BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.

Analysts’ disclosure: Both the analysts do not have any financial interests and do not hold any stocks discussed today.

Disclaimer: The commentary on BloombergQuint represents the view of external experts. Investors are advised to consult a certified financial advisor/planner when making any investments. No views shared on a BloombergQuint program or story or conversation should be construed as personal advice.

Quintillion Business Media Pvt. (BloombergQuint) is not responsible for any risk or loss that might occur as a result of using this information in any way, regardless of your interpretation of the advice.

BloombergQuint’s digital and social media platforms provide views of only SEBI registered investment advisors/analysts.